|
|
West Virginia
University is using Suboxone® to treat patients addicted to opioids such as heroin and
prescription pain relievers.
|
Suboxone's® active
ingredient, buprenorphine hydrochloride, reduces the symptoms of
opioid dependence. It serves as an alternative to methadone,
dramatically reducing opioid cravings and featuring fewer harmful
side effects than other medications.
|
Rolly Sullivan, MD |
|
Suboxone® is a combination of buprenorphine and
naloxone. Buprenorphine, a partial opioid agonist, reduces
withdrawal symptoms and blocks the effects of subsequently
administered opioids, suggesting it might help reduce illicit opioid
use. While buprenorphine treatment
can result in physical dependence, it is generally less intense
than with heroin or methadone.
|
WVU's Suboxone® program is intended only for patients interested
in recovery (not long-term maintenance).
For more information please call (304) 293-5299. After
January 21, call 598-4800.
www.health.wvu.edu Phone:
800-WVAMARS Email:communications@rcbhsc.wvu.edu
|
|
